Ligand · 7IG
7IG · 5-{4-[(3,5-difluorobenzyl)amino]phenyl}-6-ethylpyrimidine-2,4-diamine
7IG, 5-{4-[(3,5-difluorobenzyl)amino]phenyl}-6-ethylpyrimidine-2,4-diamine (C19 H19 F2 N5, 355.4 g/mol), in the MolNFT structures on GenesisL1: bound in 4 records (2 PDB entries). Every binding site with its residues within 4.5 Å, the…
- Component
- 7IG
- Formula
- C19 H19 F2 N5
- Class
- ligand
- Structures
- 4
- PDB entries
- 2
Binding sites
7IG in 4 structures; the first of them:
- 2G24 · Ketopiperazine-Based Renin Inhibitors: Optimization of the "C" Ring · 7IG A334 · binds GLN14, VAL31, ASP33, GLY35, TYR78, SER79, THR80, PRO113 and 8 more
- 2IKO · Crystal Structure of Human Renin Complexed with Inhibitor · 7IG A601 · binds GLN14, VAL31, ASP33, GLY35, TYR78, SER79, THR80, PRO113 and 8 more
- 2G24 · Ketopiperazine-based renin inhibitors: optimization of the "C" ring · 7IG A334 · binds GLN14, VAL31, ASP33, GLY35, TYR78, SER79, THR80, PRO113 and 8 more
- 2IKO · Crystal structure of human renin complexed with inhibitor · 7IG A601 · binds GLN14, VAL31, ASP33, GLY35, TYR78, SER79, THR80, PRO113 and 8 more
Residues it binds most
ALA 4, ASP 4, GLY 4, PHE 4, VAL 4, GLN 4, LEU 4, PRO 4, SER 4, THR 4 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.